期刊文献+

加味香砂六君汤治疗腹膜透析营养不良临床研究 被引量:4

Clinical Study on Modified Xiangsha Liujun Tang for Peritoneal Dialysis Malnutrition
下载PDF
导出
摘要 目的:观察加味香砂六君汤对腹膜透析(PD)患者营养状况的影响。方法:选取维持性腹膜透析营养不良患者50例,按随机数字表法分为治疗组和对照组各25例。所有患者给予常规透析治疗及对症处理,对照组给予开同营养支持,治疗组给予加味香砂六君汤口服。观察治疗前后中医证候积分、主观综合性营养评估评分(SGA)、总尿素清除指数(KT/V),并检测生化指标。结果:治疗前,2组中医证候积分比较,差异无统计学意义(P>0.05)。治疗后,2组中医证候积分较治疗前降低,且治疗组低于对照组,差异均有统计学意义(P<0.05)。治疗前,2组血生化指标比较,差异均无统计学意义(P>0.05)。治疗后,治疗组血红蛋白(Hb)、血清白蛋白(Alb)、前白蛋白(PA)、转铁蛋白饱和度(TSAT)、血钾(K)较治疗前均显著升高(P<0.05),且Alb、PA、TSAT水平高于对照组(P<0.05);对照组Hb、Alb、PA较治疗前显著升高(P<0.05)。治疗前,2组SGA评分比较,差异无统计学意义(P>0.05)。治疗后,2组SGA评分较治疗前降低,且治疗组低于对照组,差异均有统计学意义(P<0.05)。治疗前,2组KT/V比较,差异无统计学意义(P>0.05)。治疗后,2组KT/V较治疗前升高,差异有统计学意义(P<0.05)。结论:加味香砂六君汤能显著提高腹膜透析患者生活质量,改善营养不良,具有较好的应用前景。 Objective:To observe the effect of modified Xiangsha Liujun tang on nutritional status of peritoneal dialysis(PD) patients.Methods:Selected 50 cases of patients with maintenance peritoneal dialysis malnutrition and divided them into the treatment group and the control group according to the random number table,with 25 cases in each group.All patients were given routine dialysis and expectant treatment.The control group was given nutritional support,and the treatment group was given oral administration of modified Xiangsha Liujun tang.Observed the Chinese medicine syndrome scores,subjective global assessment scores(SGA) and total urea clearance indexes(KT/V) before and after treatment and detected the biochemical indexes.Results:Before treatment,there was no significant difference being found in the comparison of Chinese medicine syndrome scores in the two groups(P>0.05).After treatment,Chinese medicine syndrome scores in the two groups were lower than those before treatment,and the score in the treatment group was lower than that in the control group,differences being significant(P<0.05).Before treatment,there were no significant differences being found in the comparisons of blood biochemical criterion in the two groups(P>0.05).After treatment,hemoglobin(Hb),serum albumin(Alb),prealbumin(PA),transferrin saturation(TSAT) and serum potassium(K) in the treatment group were all obviously increased when compared with those before treatment(P<0.05);the levels of Alb,PA and TSAT were higher than those in the control group(P<0.05);and Hb,Alb and PA in the control group were evidently increased when compared with those before treatment(P<0.05).Before treatment,there was no significant difference being found in the comparison of SGA scores in the two groups(P>0.05).After treatment,the SGA scores in the two groups were decreased when compared with those before treatment,and the scores in the treatment group were lower than those in the control group,differences being significant(P<0.05).Before treatment,there was no significant difference being found in the comparison of KT/V in the two groups(P>0.05).After treatment,KT/V in the two groups was increased when compared with that before treatment,difference being significant(P<0.05).Conclusion:The application of modified Xiangsha Liujun tang can significantly enhance the life quality of peritoneal dialysis patients,improve malnutrition and has a good application prospect.
作者 陈春 项协隆 邵思思 吴芊葭 黄蔚霞 CHEN Chun;XIANG Xielong;SHAO Sisi;WU Qianjia;HUANG Weixia
出处 《新中医》 CAS 2019年第11期66-69,共4页 New Chinese Medicine
基金 温州市科技局课题(Y20170324)
关键词 腹膜透析 加味香砂六君汤 营养不良 中医证候积分 总尿素清除指数(KT/V) Peritoneal dialysis Modified Xiangsha Liujun tang Malnutrition Chinese medicine syndrome scores Total urea clearance index(KT/V)
  • 相关文献

参考文献6

二级参考文献38

  • 1韩庆烽,董捷,范敏华,刘惠兰,朱莉,汪涛.老年腹膜透析患者的临床特征[J].中华老年医学杂志,2004,23(8):574-575. 被引量:15
  • 2马特安,叶朝阳.血液透析及腹膜透析对老年患者生存期的影响及相关因素分析[J].中国中西医结合肾病杂志,2006,7(1):40-41. 被引量:18
  • 3王海燕.肾赃病学.北京:人民卫生出版社,2001:597.
  • 4黄谷香,胡平安.老年终末期糖尿病肾病的血液透析与腹膜透析的比较[J].中国医学工程,2007,15(6):497-499. 被引量:12
  • 5Schulman G, Wingard R L, Hutchison R L, et al. The effects of recombinant hman growth hormone and intradialytic parenteral nutrition in malnourished hemodialysis patients [J]. Am J Kidney Dis, 1993,21: 527.
  • 6Cianciamso B, Brmori G, et al. Nutritional status in the elderly patient with uraemia [ J ]. Nephrol Dial Transplant, 1995, 10(Suppl 6): 65.
  • 7Jager KJ, van Dijk PC, Dekker FW, etal. The epidemic of aging in renal replacement therapy: an update on elderly patients and their outcomes[]]. Clin Nephrol, 2003,60:352-360.
  • 8Teitelbaum I. Peritoneal dialysis is appropriate for elderly patients[J]. Contrib Nephrol, 2006,150:240-246.
  • 9Davies SJ, Phillips L, Naish PF, et al. Quantifying eomorbidity in peritoneal dialysis patients and its relationship to other predictors of survival[J]. Nephrol Dial Transplant, 2002,17:1085-1092.
  • 10Moist LM, Port PK, Orzol SM, et al. Prediotors of loss of residual renal function among new dialysis patients[J]. J Am Soc Nephrol, 2000,11:556-564.

共引文献580

同被引文献76

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部